Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
August 7, 2012
Patent Application Number
12580959
Date Filed
October 16, 2009
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to a vascular endothelial growth factor (VEGF)-specific human antibody, and more particularly to a human antibody including a complementarity determining region (CDR) and a framework region (FR) derived from a human antibody specifically bound to VEGF. The VEGF-specific human antibody of the present invention may be used in diagnosis of diseases caused by the VEGF-overexpression, classification of the diseases, visualization, treatment, and prognostic evaluation.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
